脑组织中钆沉积临床前评价的方法学要点:批判性评估与协调化建议——一项联合倡议
本文综述了临床前研究中脑组织钆沉积评价的方法学要点,指出回顾性临床研究报道了钆在脑内的意外长期存在,临床前模型证实线性钆对比剂较宏环状钆对比剂更易导致沉积,但尚无临床后果证据;文章批判性讨论了研究设计偏倚风险与术语选择,并提出协调化建议。
要点
- 临床前模型证实线性钆对比剂较宏环状钆对比剂更易导致脑组织钆沉积。
- 临床前研究设计常存在偏倚风险,多与实验方案设计相关。
- 目前尚未证实脑组织钆沉积的临床后果,但深入探究毒理学后果仍至关重要。
核心结论
- 临床前模型对理解钆沉积机制及潜在安全性后果至关重要,但此类模型常存在与实验方案设计相关的偏倚风险,需准确设计并选择恰当术语以保证可转化性。
研究设计与样本
- 文献综述,旨在总结并批判性讨论临床前研究准确设计与可转化性的主要方法学要点。
临床应用与阅片要点
- 临床前研究设计需关注与实验方案相关的偏倚风险,以保证结果的可转化性。
- 术语选择需准确,以避免对钆沉积相关结果的误读。
局限性
- 临床前模型可能伴随偏倚风险,常与实验方案设计相关。
- 迄今尚未证实脑组织钆沉积的临床后果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Gadolinium (Gd)-based contrast agents (GBCAs) are pharmaceuticals that have been approved for 30 years and used daily in millions of patients worldwide. Their clinical benefits are indisputable. Recently, unexpected long-term presence of Gd in the brain has been reported by numerous retrospective clinical studies and confirmed in preclinical models particularly after linear GBCA (L-GBCA) compared with macrocyclic GBCA (M-GBCA). Even if no clinical consequences of Gd presence in brain tissue has been demonstrated so far, in-depth investigations on potential toxicological consequences and the fate of Gd in the body remain crucial to potentially adapt the clinical use of GBCAs, as done during the nephrogenic systemic fibrosis crisis. Preclinical models are instrumental in the understanding of the mechanism of action as well as the potential safety consequences. However, such models may be associated with risks of biases, often related to the protocol design. Selection of adequate terminology is also crucial. This review of the literature intends to summarize and critically discuss the main methodological aspects for accurate design and translational character of preclinical studies.
引用
- Robert P, Frenzel T, Factor C, et al. Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization-A Joint Initiative. Invest Radiol. 2018. PMID: 29659381. doi:10.1097/RLI.0000000000000467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。